Icon Effective

Effective

Pain relief and
reduces inflammation

Icon Convenient

Convenient

Simple application
and ready to use

Icon Cost Effective

Cost Effective

Significant potential savings
vs competitor treatments

Click on the link below to select which content is most relevant to you.

This section of the website is intended for UK Healthcare Professionals only.

What is Oral Mucositis?

Oral mucositis is a painful inflammation of the lining of the mouth and throat (oral mucosa) and is one of the most common complications of radiation and chemotherapy cancer treatments. It is extremely painful and debilitating for patients and has a serious impact on their Quality of Life. 2,3

READ MORE
Image
Image

What is GelX®?

GelX® is an oral mucoprotectant (the medical term for a product that is used to protect mucous membrane tissue, such as oral tissue) spray, used for the prevention and treatment of oral mucositis and suitable for use in all 
ages and all ethnic cultures.1

READ MORE

Resources

We have a range of resources and information available for both oral mucositis patients and their healthcare professionals, including training resources, guides and helpful links.

READ MORE
Image

Trusted by patients & healthcare professionals…

I started using GelX after 1 cycle of chemotherapy. I had already started with a number of large mouth ulcers and was finding eating and swallowing painful. After just 2 days of using GelX, no further ulcers appeared. Throughout my chemo treatments I only had a handful of small ulcers. I can wholeheartedly say that GelX has made a significant difference to my oral comfort and enabled me to eat more normally than I could have done…A truly wonderful product!

Jayne, Patient, Wrexham

I was kindly sent GelX at the beginning of my throat cancer journey. During treatment this was a fantastic product that enabled me to have a life. Eating, drinking, smiling - GelX played a big part. I would 100% fully recommend this product to anybody without hesitation.

Jon, Patient, Surrey

I support patients with Head and Neck cancers and have found, since the introduction of GelX during radiotherapy (with or without chemotherapy), mucositis is reduced. This has meant for some patients, stronger analgesics have not been necessary or at least not required so early on during their course of radiotherapy. We find using GelX prophylactically in Head and Neck cancer patients, receiving radiotherapy, helps reduce the severity of mucositis.

Head & Neck Specialist Radiographer, Kent

We have been using GelX for about a year now. Mucositis has been improved in patients who use it consistently from the beginning of treatment.

Dr. Jennifer Turner, Consultant Clinical Oncologist

All Testimonials